Volume 12, Issue 3, July 2022
Main Menu
RP HPLC Method Development and Validation of Tolperisone HCl and Diclofenac Sodium in Bulk and Pharmaceutical Dosage Forms (Research Article)
Author(s): M. Archana*
Abstract: High-performance liquid chromatography is at present one of the most sophisticated tool for analysis. The estimation of Tolperisone HCl and Diclofenac sodium was done by RP-HPLC. The Phosphate buffer was pH 3.0 and the mobile phase was optimized consisting of Methanol: Phosphate buffer mixed in the ratio of 70:30 % v/ v. Inertsil C18 column C18 (4.6 x 150mm, 5micro m) or equivalent chemically bonded to porous silica particles was used as stationary phase. The detection was carried out using a UV detector at 260 nm. The solutions were chromatographed at a constant flow rate of 0.8 ml/min. the linearity range of Tolperisone HCl and Diclofenac sodium were found to be from 100-500 micro g/ml of Tolperisone hcl and 1-5micro g/ml of Diclofenac sodium. Linear regression coefficient was not more than 0. 999. The values of % RSD are less than 2% indicating the accuracy and precision of the method. The percentage recovery varies from 98-102% of Tolperisone HCl Diclofenac sodium. LOD and LOQ were found to be within the limit.
PAGES: 64-70 | 331 VIEWS 195 DOWNLOADS
How To Cite this Article:
M. Archana*. RP HPLC Method Development and Validation of Tolperisone HCl and Diclofenac Sodium in Bulk and Pharmaceutical Dosage Forms (Research Article). 2022; 12(3): 64-70.